Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

This research paper concludes that the combination of bedaquiline, pretomanid, and linezolid led to a favorable outcome at 6 months after the end of therapy in a high percentage of patients with highly drug-resistant forms of tuberculosis; some associated toxic effects were observed.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news